Gilead Sciences

Yahoo Finance • yesterday

Discover May 2026's Stocks That Could Be Trading Below Estimated Value

The United States market has shown robust performance, rising 1.8% over the last week and climbing 28% in the past year, with earnings projected to grow by 17% annually. In this thriving environment, identifying stocks that are trading bel... Full story

Yahoo Finance • 5 days ago

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio

Gilead Sciences Inc. (NASDAQ:GILD) is one of the cheap NASDAQ stocks to buy right now. On May 21, Gilead Sciences completed the acquisition of Tubulis GmbH, a Germany-based biotechnology company, for $3.15 billion in upfront payments plus... Full story

Yahoo Finance • 5 days ago

Three Stocks That May Be Trading Below Their Estimated Value In May 2026

Over the last 7 days, the United States market has risen by 1.1%, contributing to an impressive 29% climb over the past year, with earnings forecasted to grow by 17% annually. In such a robust environment, identifying stocks that may be tr... Full story

Yahoo Finance • 8 days ago

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index advancing 1.1% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 9 days ago

Hepatic Impairment Market Analysis Report 2026-2036 Featuring AbbVie, Astellas Pharma, Gilead Sciences, F. Hoffmann La Roche, and Takeda Pharmaceuticals

Company Logo The hepatic impairment market is an essential segment within healthcare, focusing on managing liver conditions like hepatitis, NAFLD, and cirrhosis that impair liver function. The market is set for significant growth, driven... Full story

Yahoo Finance • 10 days ago

Cigna downgraded, Humana upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Deutsche Bank upgraded Humana (HUM) to... Full story

Yahoo Finance • 11 days ago

Polymyositis Market Research Report 2026-2036: Competitive Landscape is Dominated by Major Players Such As Teva Pharmaceuticals, Gilead Sciences, Roche, AbbVie, and Pfizer

Company Logo The polymyositis market is witnessing notable growth driven by the increasing prevalence of this autoimmune disease, particularly among older adults. Polymyositis leads to muscle inflammation and weakness, highlighting the ur... Full story

Yahoo Finance • 12 days ago

Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion

Company Logo The global hepatic cirrhosis market is expanding rapidly, fueled by increasing liver disease cases, advanced treatment options, and improved healthcare infrastructure. Conditions like hepatitis, alcohol abuse, and metabolic d... Full story

Yahoo Finance • 12 days ago

Compugen Q1 Earnings Call Highlights

Compugen (NASDAQ:CGEN) said it remains on track to report interim progression-free survival data in the first quarter of 2027 from its MAIA-ovarian study, as the clinical-stage immuno-oncology company outlined first-quarter 2026 results an... Full story

Yahoo Finance • 15 days ago

FDA leadership fallout continues as acting CDER Director Hoeg expected to depart

[FDA headquarters in Washington DC.] JHVEPhoto * Just days after Marty Makary left [https://seekingalpha.com/news/4591441-fda-commissioner-makary-getting-fired-tuesday] as FDA commissioner on May 12, Tracey Beth Hoeg, the acting leader... Full story

Yahoo Finance • 15 days ago

Gilead Sciences prices $3B multi-tranche senior notes offering

Gilead Sciences (GILD [https://seekingalpha.com/symbol/GILD]) announced that it has priced senior unsecured notes [https://seekingalpha.com/pr/20516811-gilead-prices-3-billion-of-senior-unsecured-notes] totaling $3B in a public offering.... Full story

Yahoo Finance • 16 days ago

Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial

argenx, Bayer, Boehringer Ingelheim, Genentech, Gilead, GSK, Merck, Novo Nordisk, Takeda, and Vertex share how they are redefining engagement across sales, marketing, and medical PLEASANTON, Calif., May 14, 2026 /PRNewswire/ -- Veeva Syst... Full story

Yahoo Finance • 18 days ago

Trinity's TGaS Advisors Announces Winners of 9th Annual Best of Benchmark Awards

Boehringer Ingelheim, Genentech, Gilead, GSK, Lilly, Neurelis, Novartis and Sanofi Recognized for Operational Excellence WALTHAM, Mass., May 12, 2026 /PRNewswire/ -- Trinity, a leader in strategy, insights and analytics for the life scien... Full story

Yahoo Finance • 20 days ago

Stifel Remains Bullish on Tango Therapeutics (TNGX)

Tango Therapeutics, Inc. (NASDAQ:TNGX) is one of the best performing healthcare stocks so far in 2026. Stifel lifted the price target on Tango Therapeutics, Inc. (NASDAQ:TNGX) to $40 from $24 on April 27, maintaining a Buy rating on the sh... Full story

Yahoo Finance • 21 days ago

Most healthcare companies report higher Y/Y EPS in strong earnings week

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images Healthcare companies delivered strong earnings this week, with 18 out of 20 companies beating EPS estimates and 15 t... Full story

Yahoo Finance • 21 days ago

Trump says unaware of a plan to fire FDA commissioner

Anna Moneymaker/Getty Images News Amid multiple reports suggesting that President Donald Trump has signed off on a plan to oust FDA commissioner Marty Makary, Trump said late Friday that he is completely unaware of such a proposal. The W... Full story

Yahoo Finance • 22 days ago

Stocks making the biggest moves premarket: Cloudflare, Akamai Technologies, JFrog, Trade Desk & more

Check out the companies making the biggest moves premarket: Akamai Technologies — Shares surged 27% after the cybersecurity and cloud computing company said a leading U.S.-based frontier model provider has committed to $1.8 billion over se... Full story

Yahoo Finance • 24 days ago

Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update

Galapagos’ name change to Lakefront Biotherapeutics approved at the Company’s EGM (Euronext & NASDAQ: LKFT) Collaboration Agreement with Gilead to advance potential First and Best-in-Class T Cell Engager expected to close in the Secon... Full story

Yahoo Finance • 25 days ago

1 S&P 500 Stock to Own for Decades and 2 We Avoid

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds. Even among blue-chip stocks, not... Full story

Yahoo Finance • 26 days ago

Schwab flags a $1 trillion threat looming over health care

Health care stocks staged a comeback in 2025 after months of weak sentiment, buoyed by improving earnings expectations and growing enthusiasm around artificial intelligence. By early 2026, much of the sector had regained technical strength... Full story